Lamivudine / Zidovudine ViiV H-W-672

Name of the medicinal product Lamivudine / Zidovudine ViiV (previously Lamivudine / Zidovudine GSK)
Opinion holder ViiV Healthcare UK Limited
Greenford Road
Greenford, Middlesex UB6 0NN
United Kingdom
Active substance Lamivudine / zidovudine
International non-proprietary name or common name Lamivudine / zidovudine
Pharmaco-therapeutic group Antivirals for systemic use
ATC code J05AR01
Therapeutic indication Lamivudine/zidovudine is indicated as part of antiretroviral combination therapy for the treatment of human immunodeficiency virus (HIV) infected adults and children.
Orphan medicinal product designation date Not applicable

This medicine was previously called: Lamivudine/Zidovudine GSK

*This document includes:

Annex I - Summary of product characteristics
Annex IIA - Manufacturer responsible for batch release
Annex IIB - Recommendations to the opinion holder - conditions of use
Annex IIIA - Labelling
Annex IIIB - Package leaflet

Please note that the size of the above document can exceed 50 pages.
You are therefore advised to be selective about which sections or pages you wish to print.


How useful was this page?

Add your rating